BTG PLC has added Irish inferior vena cava filter firm Novate Medical Ltd. to complement its vascular device portfolio. The acquisition, announced Sept. 7, will cost $20m upfront, plus up to $130m in milestone payments.
Novate's Sentry device was 510(k)-cleared in 2017 and is the first bioconvertible IVC filter, meaning it integrates into the vessel...